A summary of Von Willebrand factor (VWF), fibrin, and fibrinogen

By SWA

Von Willebrand factor (VWF), fibrin, and fibrinogen are essential components of the blood clotting process, each with distinct functions:

  1. Fibrinogen Production:

    • Fibrinogen is produced primarily in the liver, specifically by hepatocytes (liver cells). It is synthesized and released into the bloodstream.
    • The production of fibrinogen is regulated by various factors, including cytokines and hormones, such as interleukin-6 (IL-6) and interleukin-1 (IL-1). These factors can stimulate the liver to produce more fibrinogen in response to inflammation or injury.
    • Fibrinogen is considered a soluble plasma protein, meaning it circulates in the blood in an inactive form.

 Von Willebrand Factor (VWF):

    • VWF facilitates platelet adhesion and aggregation.
    • It acts as a bridge between platelets and damaged blood vessel walls.
    • VWF is produced by endothelial cells and megakaryocytes and plays a role in stabilizing factor VIII.

  2. Fibrinogen:

    • Fibrinogen is a soluble plasma protein produced in the liver.
    • It is enzymatically converted into fibrin when blood clotting is initiated.
    • Fibrin forms a mesh-like structure in blood clots, trapping blood cells and providing structural support.

  3. Fibrin:

    • Fibrin is the insoluble protein that constitutes the framework of blood clots.
    • It is formed from fibrinogen through enzymatic cleavage, primarily by thrombin.
    • Fibrin traps blood cells within the clot, ensuring clot stability.

These proteins work in conjunction with other factors in the coagulation cascade to orchestrate the formation of blood clots, which are crucial for hemostasis and preventing excessive bleeding when blood vessels are damaged.

Comments

Post a Comment

Popular posts from this blog

Is ME CFS Spinal Muscular Atrophy (SMA)?

By SWA
After a 70-year journey filled with multiple incorrect diagnoses and just as many inappropriate treatments, I finally found an answer to my progressive muscle weakness. Throughout this time, I faced insults and was labeled lazy for my inability to walk long distances or up hills, climb steps, or carry heavy loads. I couldn't ride a bike because sitting on the saddle was impossible. My school grades suffered due to insufficient performance in sports. Instead of receiving comfort from my parents, I was pushed into hard work to strengthen my muscles. Doctors also advised me to exercise my muscles. My life continued with reduced activity, as I had to avoid or quit jobs where standing for extended periods was required or where I couldn't support my skeletal muscle weakness by bracing my elbows. The most excruciatingly painful and weakest period, when I could barely walk, occurred at age 20, during pregnancy. In 2008, an MRI referred by my endocrinologist for permanent adrenal
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By SWA
Image
Could a virus be the stimulus for cytokine production?   It is well established, but rarely  tested, that a cytokine storm is an overactive immune response characterized by the excessive release of pro-inflammatory cytokines. ( ANA, CRP, and CBC tests are necessary) It can occur in various conditions, such as severe infections (e.g., COVID-19), (and other viruses), autoimmune diseases, and after certain treatments.  Serositis and lymphopenia are common features of systemic lupus erythematosus following SARS-CoV-2 infection: A case report and literature review These cells are called NKG2D+CD8+ T cells and researchers say their aggressive response is responsible for neurological damage suffered from infections beyond just Zika, like COVID-19 and even septic shock. The aggressive response is the result of the body producing large amounts of inflammatory proteins called cytokines, which in moderation help to coordinate the body’s response in battling an infection or injury by
Read more

Strange fibrous clots

By SWA
 AI evaluated: The image shows a table listing various proteins with their corresponding percentages and ranks. These results appear to be from a protein analysis, possibly from a blood sample or a proteomic study. Each row represents a different protein, with the following columns: Protein Name: The name of the protein detected in the sample. Percentage (%): The relative abundance of each protein, indicating its proportion in the sample. Rank (#): The rank of each protein based on its relative abundance. Here is a brief interpretation of some of the listed proteins and their potential significance: Fibrinogen beta chain (35.2848%) and Fibrinogen gamma chain (16.0694%): High levels of fibrinogen proteins suggest a response to injury or inflammation, as fibrinogen is essential for blood clot formation. Hemoglobin subunit beta (14.0401%) and Hemoglobin subunit alpha (2.8530%): Presence of hemoglobin subunits indicates red blood cells or hemolysis in the sample. Actin, cytoplasmic 1
Read more